BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Modufolin: Phase I/II started

Isofol began the open-label, Swedish Phase I/II LARS2 trial to evaluate 10, 50 and 100 mg/m 2 Modufolin in combination with 500 mg/m...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >